Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I just send a mail to Stephanie, but no reply!
52900 on the bid for 5.2 dollar !
They are accumulating and keeping the price low.
Waiting for the pop.
I GUESS : 249999999,1239 + A PEANUT
I will vote the BLUE card and BURN the WHITE card !
Stephen is driving now in his new lambo !
https://www.pharmasalmanac.com/articles/the-advantage-of-having-a-drug-development-company-behind-manufacturing
I will light my fireplace with the white card !
Thank you for this info and i will destroy the white card.
And how can i get those Proxy cards ?
Maybe this is a stupid question but can somebody explain me how i can vote ?
I really don't want that my vote goes automtically to this current BOD !
Thx
Corporal Punishment Poll For PPHM
If you agree with Ronin's position on current state of Peregrine management, and the potential addition of new board members add your name to the list. Big prize for the winners. Higher stock price
.
?
Copy and paste with your name added. Mods will delete older versions to reduce the number of these posts.
Good luck!
1. Loofman
2. Cheynew
3. Stoneroad
4. Hayward
5. Pphmfan
6. Hawkfan1
7. RevMonster
8. Corporal
9. Internet forum user
10. BioBS2012
11. Chevalblamc47
12. Ku
13. Mauriziomh
When you see on twitter i think it's not astronomical !
Waiting for the first impressions of the pro's.
1/5 for current shares is still better then 5/5 times after a reverse split of 1/7 !
Good days are coming ! Countdown to ESMO.
First we had PM 101 buys and then the crash !!
Now we have all the time 200 shares .
After some number research :
101 Switching Protocols The requester has asked the server to switch protocols and the server has agreed to do so.
200 OK Standard response for successful HTTP requests
So no stress and relax all is OK
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
Michael J. GrayEmail author, Jian Gong, Michaela M. S. Hatch, Van Nguyen, Christopher C. W. Hughes, Jeff T. Hutchins and Bruce D. Freimark
http://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-016-0708-2
Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence - Research and Markets
Over the 2014-2021 period, the value of the Asia-Pacific markets for breast cancer therapeutics is expected to increase at a compound annual growth rate of 8.5%, from $1.9 billion to over $3.4 billion. Rising breast cancer prevalence and increasing use of premium targeted therapies along with new product approvals will lead to significant market growth over the forecast period, despite generic sales erosion resulting from patent expiration.
With over 700 active pipeline molecules, most of the investigational drug candidates are being evaluated for the first-line or second-line treatment of advanced-stage breast cancer, featuring new combination therapies, targeted therapies, and promising immunotherapies, as well as chemotherapy drug candidates.
Breast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer in women worldwide, accounting for 16% of all female cancers, making the disease exceedingly prevalent. In the past, breast cancer occurred less in women in Asia than women in Western countries. However, recent studies show that breast cancer is being diagnosed more frequently in women living in Asia, especially among younger women.
The market is set to be driven by a number of new approvals for drugs and an increased uptake of premium targeted therapies. Nevertheless, significant unmet need remains for products that can improve overall survival rate, time to disease progression, and overall response.
http://www.nbc-2.com/story/31414547/breast-cancer-therapeutics-in-asia-pacific-markets-to-2021-growth-driven-by-increasing-uptake-of-premium-priced-biologics-and-rising-prevalence
Enjoy the little things in life for one day you'll look back and realize they were the big things !!
101 is the emergency number in Belgium like 911 in the US
Are they awake in Tustin ? Please do something before it's too late !
SOON is now not tomorrow not next week but NOW.
WAKE UP
According the website of clinical trial yes but still not recruiting.
https://clinicaltrials.gov/ct2/show/NCT02673814?term=bavituximab&rank=16
Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer
Estimated Enrollment: 198
Study Start Date: February 2016
Estimated Study Completion Date: April 2018
Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)
So we will know it soon !
Antibody-Mediated Blockade of Phosphatidylserine Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinomas Xenografts
with bavituximab
http://link.springer.com/article/10.1245%2Fs10434-016-5107-5
AZN halts cancer drug combination.
But not with BAVI !
http://www.bloomberg.com/news/articles/2015-10-09/astrazeneca-temporarily-halts-cancer-drug-combination-studies
Zacks Rating Disclosure on Peregrine Pharmaceuticals
Peregrine Pharmaceuticals (NASDAQ:PPHM) remains a strong buy in the latest set of rankings. The counter has received an average rating of 1 by 2 analysts. Zacks research analysts are highly optimistic on the counter and has given it a short term rating of 1, indicating that it is a Outperform.
Peregrine Pharmaceuticals (NASDAQ:PPHM): 2 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $4.5 in Peregrine Pharmaceuticals (NASDAQ:PPHM). However, the stock price could fluctuate by $ 0.71 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $5 price target with the lower price estimate is calculated at $4
insert-text-here
Swiss trial of Canadian Ebola vaccine suspended due to unexpected side-effects
It's time to make a cocktail with some Bavi !
https://ca.news.yahoo.com/swiss-researchers-suspend-trial-ebola-vaccine-unexpected-side-144248658.html
Whopa 1.55 pre-market.
Peregrine Pharmaceuticals Inc (NASDAQ:PPHM) recorded a -10.96% change in the short interest in the past month. The 3-month %change in short interest stands at 2.83%. A decrease in 1-month short interest eases the pressure off the stock while an increase is a negative overhang. The monthly shorted shares now measure at 0.042 times the total shares outstanding. The companys short ratio is at 5.14. A higher ratio is bearish for the counter while a low ratio eases some negative pressure. The average volume for the past 20 trading days is 322,140 shares. Volume for the last 20 trading sessions stands at 0.95% of the outstanding shares. Peregrine Pharmaceuticals Inc (NASDAQ:PPHM) remains a strong buy in the latest set of rankings. The counter has received an average rating of 1 by 3 analysts. Research Analysts at Zacks has the counter a rating of 3, which implies that investors can hold their investments in the company. It is advised that fresh investments be made in the counter only when it is undervalued.
Thx for all the advise but i will buy some more
Next month we will know more about the liver results !
I don't understand why most of you people are upset this will skyrocket high or go down till the ground .
I believe in the science and we will make it one way or the other .
Go PPHM
Then we can go now for a 10 year up trend !
go pphm
Yes Lemmy
Why not? Some people believe in the technology and want the best for their friends! So what 's wrong to ask here for more information about the tests? My father died four months ago of lung cancer for him it's too late. Ralphazard good luck and I hope the best for your friend.
I think this is very interesting !
Dr Steven Rosberg
http://www.nytimes.com/2014/05/09/health/doctors-use-patients-immune-cells-to-shrink-cancer-tumors.html?partner=rss&emc=rss&_r=2
and also in the dutch newspapers :
http://www.hln.be/hln/nl/33/Fit-Gezond/article/detail/1881406/2014/05/09/Doorbraak-in-kankeronderzoek-Tumor-bestreden-met-eigen-immuunsysteem.dhtml
CP,
I know a person before the test, but I do not know whether he is fit the profile. Let me know when you know more about the UZA.
If you need more info you can always send me a mail .
mherbosch@gmail.com
grtz
I'm from Belgium and over here it's already Pm so no problem for the moment !
I will do it for the PPHM crew .
Go go Green
I go drink some bacardi maybe everything will turn green after a few glases
Just add some more pphm ! go go go